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Aims: Due to the increasing number of solid organs transplantations, emergency abdominal surgery in
transplanted patients is becoming a relevant challenge for the general surgeon. The aim of this systematic review
of the literature is to analyze morbidity and mortality of emergency abdominal surgery performed in transplanted
patients for graft-unrelated surgical problems.
Methods: The literature search was performed on online databases with the time limit 1990–2015. Studies describing
all types of emergency abdominal surgery in solid organ transplanted patients were retrieved for evaluation.
Results: Thirty-nine case series published between 1996 and 2015 met the inclusion criteria and were selected for the
systematic review. Overall, they included 71671 transplanted patients, of which 1761 (2.5 %) underwent emergency
abdominal surgery. The transplanted organs were the heart in 65.8 % of patients, the lung in 22.1 %, the kidney in 9.
5 %, and the liver in 2.6 %. The mean patients’ age at the time of the emergency abdominal surgery was 49.4 ± 7.
4 years, and the median time from transplantation to emergency surgery was 2.4 years (range 0.1–20). Indications for
emergency abdominal surgery were: gallbladder diseases (80.3 %), gastrointestinal perforations (9.2 %), complicated
diverticulitis (6.2 %), small bowel obstructions (2 %), and appendicitis (2 %). The overall mortality was 5.5 %
(range 0–17.5 %). The morbidity rate varied from 13.6 % for gallbladder diseases to 32.7 % for complicated
diverticulitis. Most of the time, the immunosuppressive therapy was maintained unmodified postoperatively.
Conclusions: Emergency abdominal surgery in transplanted patients is not a rare event. Although associated
with relevant mortality and morbidity, a prompt and appropriate surgery can lead to satisfactory results if
performed taking into account the patient’s immunosuppression therapy and hemodynamic stability.
Keywords: Emergency abdominal surgery, General surgery, Solid organ transplantation, Liver transplantation,
Kidney transplantation, Heart transplantation, Lung transplantation, Systematic review
Abbreviations: CT, Computed tomography; EAS, Emergency abdominal surgeryBackground
Organ transplantation is considered as the most effective
treatment for end-stage disease of the heart, lung,
pancreas, liver, and kidney, with approximately 28000
solid organs transplanted every year in Europe and USA,
and overall 114690 organs transplanted in 2012
worldwide [1]. The high number of transplantations per
year and the long-term graft survival had contributed to* Correspondence: nic.deangelis@yahoo.it
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surgeon to encounter a transplanted patient with a graft-
unrelated surgical problem [2–5].
The management of graft-unrelated acute abdominal
disease in transplanted patients generally adheres to the
fundamental principles of any surgical treatment.
Preoperative evaluation should consider that transplanted
patients are chronically immunosuppressed, and although
most of them achieve an excellent functional capacity and
are able to live normal productive lives, they remain at
increased risk for any surgical complication, particularly
infectious. Moreover, the clinical presentation of many
disease may be different from the general population,le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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the disease severity [5]. Another important issue is the
potential impact of any operative procedure on the
functional capacity of the transplanted organ, which shows
to have a reduced clinical reserve compared to the native
organ. Even modest intra-operative insults, such as
hypotension, may negatively affect the transplanted organ,
and thus, when several options are available, the most
cautious, conservative, minimally invasive, and standard-
ized surgical approach should be preferred in these
patients [5].
When considering the incidence of several common
general surgical problems and the ever-larger cohort of
transplanted patients living and functioning under
chronic immunosuppression [6], it becomes apparent
that all general surgeons, especially outside of transplant
centers, should be familiar with the factors that influ-
ence the surgical outcomes in this particular subset of
patients, along with the issues that are likely to affect the
optimal surgery timing and the postoperative cares [6].
The aim of the present systematic review is to provide an
exhaustive analysis of the current available literature about
the outcomes of emergency abdominal surgery (EAS)
performed in transplanted patients for graft-unrelated
abdominal diseases. The evidence-based assessment of EAS
morbidity and mortality in transplanted patients may help
the surgeon and clinician in the decision making process
face to the challenging management of acute abdominal
disease in this particular subset of patients.Materials and methods
The methodological approach included the development
of selection criteria, definition of search strategies,
assessment of study quality, and abstraction of relevant
data. The PRISMA statements checklist for reporting a
systematic review was followed [7].Study inclusion criteria
The study selection criteria were defined before initiating
data collection for proper identification of studies eligible
for the analysis. All studies in which the primary objective
was to describe EAS for graft-unrelated diseases in trans-
planted patients were retrieved and analyzed.Types of study
Epidemiological studies, interventional trials, case–control
studies, cross-sectional studies and case series including
more than four patients [8] were considered eligible for
inclusion in this systematic review. Case reports, review
articles, systematic reviews, meta-analyses, conference
abstracts, letters and commentaries were not considered.Types of participants
Patients who had received a solid organ transplantation
(heart, lung, liver, pancreas, or kidney) presenting with graft-
unrelated surgical abdominal diseases were considered.
Types of intervention
All types of surgical abdominal emergencies (e.g.
appendectomy, cholecystectomy, colectomy, bowel
resection, gastric resection, surgical repair of incisional
hernia, explorative laparotomy) were considered.
Types of outcome measures
The primary outcomes were the post-operative 90-day
morbidity and mortality following EAS. All secondary
parameters (e.g. hospital stay and immunosuppressive ther-
apy) reported in the selected studies were also evaluated.
Literature search strategy
A literature search was performed on the following online
databases: MEDLINE (through PubMed), EMBASE,
Scopus, Cochrane Oral Health Group Specialized Register,
and ProQuest Dissertations and Thesis Database. To
increase the probability of identifying all relevant articles,
a specific research equation was formulated for each
database, using the following keywords and/or MeSH
terms: emergency, emergency surgery, urgent surgery,
appendicitis, diverticulitis, perforation, cholecystectomy,
colectomy, appendectomy, cholecystitis, humans, adult,
transplant, transplantation, solid organ transplantation,
transplant patient, transplanted patient.
In addition, the reference lists from the eligible studies
and relevant review articles (not included in the system-
atic review) were crosschecked to identify additional
records. The literature search was performed on January
2016 and was restricted to articles published since 1990.
Only studies written in English and meeting the selec-
tion criteria were reviewed.
Study selection and quality assessment
The titles and abstracts of the retrieved studies were
independently and blindly screened for relevance by two
reviewers (FE and VL). To enhance sensitivity, records
were removed only if both reviewers excluded the record
at the title screening level. All disagreements were
resolved by discussion with a third and fourth reviewers
(NdeA and RM). Subsequently, both reviewers per-
formed a full-text analysis of the selected articles. Two
reviewers independently assessed the risk of bias and
study quality by using appropriate tools. Precisely, The
NICE guidelines [9] was used for the quality assessment
of case series, which was rated on a 8 points scale by
answering eight questions concerning the following
aspects:, study setting (i.e. uni or multicentric), study
hypothesis/objective, case definition, outcome definition,
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analysis. Additionally, the Grading of Recommendations
Assessment Development and Evaluation (GRADE)
system [10] was used to enable consistent judgment of the
“body of evidence” included in the systematic review.
GRADE specifies four categories: high, moderate, low, and
very low. In the context of a systematic review, the quality
of evidence reflects the confidence that the estimates of
the effect are correct and overpasses the individual study
risk of bias by evaluating the following aspects: study
design, imprecision, inconsistency, indirectness of study
results, and publication bias.Data extraction
Data extracted from the studies included in the system-
atic review were processed for qualitative and possibly
quantitative analyses. Outcome measures (mean and
median values, standard deviation, and ranges) were
extracted for each variable. Average morbidity and
mortality rates were calculated.Fig. 1 Flow chart of the study search, selection, and inclusion. Example of
surgery[Title/Abstract]) OR urgent surgery[Title/Abstract]) OR appendicitis[Ti
Abstract]) OR cholecystectomy[Title/Abstract]) OR colectomy[Title/Abstract]
AND Humans[Mesh] AND English[lang] AND adult[MeSH]) AND (((((transpla
transplantation[Title/Abstract]) OR transplant patient[Title/Abstract]) OR tranResults
Literature search and selection
Out of the 1428 articles initially identified, 39 articles [2,
4, 11–47] met the inclusion criteria and were selected for
the systematic review. The flow chart of studies identifica-
tion and inclusion/exclusion process is shown in Fig. 1.
Study characteristics
The selected studies were published between 1996 and
2015 and they were all case series [2, 4, 11–47]. They
were carried out in ten different countries, particularly
in Europe (n = 11) [13, 14, 18, 24, 28–30, 34, 35, 38, 40],
North America (n = 24) [2, 4, 11, 12, 15–17, 19, 21–
23, 25–27, 31, 33, 36, 37, 39, 41, 43–46], Asia and
Pacific (n = 4) [20, 32, 42, 47]. The overall number
of transplanted patients considered was 71671. Of
these patients, 1761 (2.5 %) underwent EAS for
graft-unrelated acute diseases. The mean age of the
patients undergoing EAS was 49.4 ± 7.4 years, and the
median time from transplantation to the required
emergency operation was 2.4 years (range 0.1–20). Thesearch equation: emergency[Title/Abstract]) OR emergency
tle/Abstract]) OR diverticulitis[Title/Abstract]) OR perforation[Title/
) OR appendectomy[Title/Abstract]) OR cholecystitis[Title/Abstract])
nt[Title/Abstract]) OR transplantation[Title/Abstract]) OR solid organ
splanted patient[Title/Abstract])
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lung in 22.1 %, the kidney in 9.5 % and the liver in 2.6 %.
EAS was necessary because of the following conditions:
gallbladder diseases (80.3 %), gastrointestinal perforations
(9.2 %), complicated diverticulitis (6.2 %), small bowel ob-
struction (2 %), appendicitis (2 %), and miscellaneous
(0.3 %). The overall mortality rate was 5.5 %.
The studies concerning gallbladder diseases [4, 11–23]
requiring EAS in transplanted patients are displayed in
Table 1. Acute cholecystitis, with and without gallstones
(including hydrops, empyema, gangrene and perfor-
ation), was the most common primary diagnosis,
followed by gallstones without cholecystitis, and chronic
cholecystitis. Laparoscopic cholecystectomy was per-
formed in 72 % of EAS cases and laparotomy in 23.1 %.
In 1.9 % of patients a surgical cholecystostomy was
carried out. In 42 patients, the type of surgery performed
was not precisely described. The morbidity rate was
13.6 %. The most frequent EAS-related complicationsTable 1 Reports of gallbladder diseases requiring EAS after solid org
Transplanted organ (n) EAS charac
Authors, Year Heart Lung Heart-Lung Kidney Patients un
EAS (n)
Taghavi S et al.,
2015 [11]
9186 258
Kilic A et al.,
2013 [12]
23854 1054
Lahon B et al.,
2011 [13]
351 11
Paul S et al.,
2009 [4]
208 13
Sarkio S et al.,
2007 [14]
1608 17
Takeyama H et al.,
2006 [15]
402 2
Englesbe MJ et al.,
2005 [16]
168 7
Richardson WS et al.,
2003 [17]
518 19
Hoekstra HJ et al.,
2001 [18]
125 1
Gupta D et al.,
2000 [19]
143 30 5 6
Lord RV et al.,
1998 [20]
455 133 57 13
Bhatia DS et al.,
1997 [21]
349 5
Milas M et al.,
1996 [22]
175 5
Sharma S et al.,
1996 [23]
240 2
Total 26304 10033 62 1608 1413
EAS emergency abdominal surgery, OC open cholecystectomy, LC laparoscopic choincluded: respiratory failure, pneumonia, deep venous
thrombosis, pulmonary embolism, postoperative haem-
orrhage, and surgical site infection. The overall mortality
was 3.4 %. The median hospital stay was 9.3 days
(range 1–38).
The studies concerning gastrointestinal perforations
requiring EAS in transplanted patients [4, 13, 18, 21,
23–36] are shown in Table 2. The most frequent causes
of perforation were: diverticulitis (this disorder and its
complications are described below and in Table 3);
peptic disease; ischemia; chronic inflammatory bowel
disease; iatrogenic factors; post-transplantation lympho-
proliferative disorders; enteritis and colitis caused by
Clostridium difficile or Cytomegalovirus. In immunosup-
pressed transplanted patients, the signs and symptoms
of perforation were often absent or non-specific. There-
fore, the interval from clinical onset to surgery was very
large, ranging from 2 to 8 days. The diagnosis of
perforation was confirmed by an abdominal and pelvican transplantation
teristics and outcomes






2.81 OC (58), LC (190),
n/a (10)
48 (18.6) 0 (0)
4.42 OC (233), LC (795),
CS (26)
126 (12.0) 37 (3.5)
3.13 OC (11) n/a 1 (9.1)
6.25 OC (4), LC (9) n/a 0 (0)
1.06 n/a (17) n/a 1 (5.9)
0.50 n/a (2) n/a 0 (0)
4.17 LC (7) 2 (28.6) 1 (14.3)
3.67 OC (4), LC (15) 9 (47.4) 1 (5.3)
0.80 LC (1) n/a 0 (0)
3.37 OC (6) 3 (50) 3 (50)
2.02 n/a (13) 4 (30.8) 1 (7.7)
1.43 OC (5) n/a 2 (40)
2,86 OC (5) 0 (0) 0 (0)
0.83 OC (1), CS (1) 0 (0) 1 (50)
3.72 OC (327), LC (1017),
CS (27), n/a (42)
192 (13.6) 48 (3.4)
lecystectomy, CS cholecystostomy, n/a not available
Table 2 Reports of gastrointestinal perforations requiring EAS after solid organ transplantation
Transplanted organ (n) EAS characteristics and outcomes










Timrott K et al.,
2014 [24]
342 1074 21a 1,48 BR (21) n/a n/a
Lee JT et al.,
2014 [25]
2406 10 0.42 CR (10) 6 (60) 3 (30)
Cruz RJ Jr et al.,
2012 [26]
5677 6 0.11 n/a (6) n/a 2 (33.3)
Boutros M et al.,
2012 [27]
814 2 0.25 CR (2) n/a 0 (0)
Boutros M et al.,
2012 [27]
430 3 0.70 CR (3) n/a 1 (33.3)
Jorgensen KK et al.,
2012 [28]
69 4 5.80 CR (4) n/a 0 (0)
Lahon B et al.,
2011 [13]
351 2 0.57 CR (2) n/a 0 (0)
Paul S et al.,
2009 [4]
208 8 3.85 n/ac (7), CR (1) n/a 3 (37.5)
Catena F et al.,
2008 [29]
1611 46 2.86 CR (21), BR (15),
UC (10)
n/a 11 (23.9)
Ho GT et al.,
2005 [30]
413 4 0.97 CR (4) n/a 0 (0)
Keven K et al.,
2004 [31]
702 2 0.28 CR (2) 1 (50) 1 (50)
Karakayali H et al.,
2002 [32]
1038 6 0.58 UC (4), CR (2) n/a 0 (0)
Hoekstra HJ et al.,
2001 [18]
125 2 1.60 BR (1), CR (1) n/a 0 (0)
Andreoni KA et al.,
1999 [33]
1417 26 1.83 CR (26) n/a 1 (3,8)
Mueller XM et al.,
1999 [34]
93 2b 2.15 UC (1), CS (1) 0 (0) 0 (0)
Bhatia DS et al.,
1997 [21]
349 7 2.01 CR (7) 3 (42.9) 0 (0)
Wekerle T et al.,
1997 [35]
124 4 3.23 n/ac (2), CR (2) n/a 4 (100)
Beaver TM et al.,
1996 [36]
60 3 5.00 HP (3) 0 (0) 1 (33,3)
Sharma S et al.,
1996 [23]
240 2 0.83 n/ac (2) 0 (0) 1 (50)
Total 6589 1024 1942 7988 160 0.91 BR (37), CR (87),
HP (3), UC (15),
CS (1), n/a (17)
n/a 28 (17.5)
EAS emergency abdominal surgery, BR bowel resection, CR colon resection, UC ulcer closure, CS colostomy, HP hartmann procedure, n/a not available
a3out of 21 were after heart transplantation; b1 Duodenal ulcer perforation and 1 iatrogenic colon perforation; cPeptic ulcer disease
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whereas abdominal X-rays were sufficient in some cases.
The perforation was located at the level of colon in
58.4 % of patients, small bowel (including jejunum and
ileum) in 33.8 %, stomach and duodenum in 7.8 %. All
operations were performed by open approach. The
surgical procedures carried out were: colon resection
with primary anastomosis in 54.3 % of cases; small bowelresection with anastomosis in 23.2 %; stomach and duo-
denum ulcer closure in 9.4 %; Hartmann’s procedure in
1.9 %; and colostomy in 0.6 %. In 10.6 % of cases, the
type of surgery performed could not be traced back.
Generally, the immunosuppressive therapy was main-
tained unmodified postoperatively. The median hospital
stay was 22.2 days (range 9–87), with an overall mortal-
ity rate of 17.5 %.
Table 3 Reports of complicated diverticulitis after solid organ transplantation
Transplanted organ (n) EAS characteristics and outcomes
Authors, Year Liver Heart Lung Heart-Lung Kidney Patients undergoing
EAS (n)






Larson ES et al.,
2014 [37]
314 7 2.23 HP (7) n/a 1 (14.3)
Scotti A et al.,
2014 [38]
717 9 1.26 HP (9) 5 (55.6) 0 (0)
Reshef A et al.,
2012 [39]
5329a 9 0.17 CR (9) 5 (55.6) 2 (22.2)
Reshef A et al.,
2012 [39]
5329a 12 0.23 CR (12) 6 (50) 0 (0)
Reshef A et al.,
2012 [39]
5329a 4 0.08 CR (4) 3 (75) 1 (25)
Reshef A et al.,
2012 [39]
5329a 12 0.23 CR (12) 9 (75) 4 (33.3)
Paul S et al.,
2009 [4]
208 2 0.96 CR (2) n/a 2 (100)
Dalla Valle R
et al., 2005 [40]
875 8 0.91 HP (5), S (2),
n/a (1)
6 (75) 1 (12.5)
Miller CB et al.,
2006 [41]
229 3 1.31 HP (3) n/a 0 (0)
Goldberg JH et al.,
2006 [2]
530 435 47 11 1.09 HP (11) n/a 1 (9.1)
Qasabian RA et al.,
2004 [42]
639 248 66 9 0.94 HP (6), S (1),
S + DLI (2)
0 (0) 1 (11.1)
Karakayali H et al.,
2002 [32]
1038 2 0.19 CR (2) n/a 0 (0)
Hoekstra HJ et al.,
2001 [18]
125 5 4 HP (3), S (2) n/a 0 (0)
Khan S et al.,
2001 [43]
233 35 2 0.75 HP (2) 1 (50) 0 (0)
Lederman ED et al.,
1998 [44]
1137 13 1.14 HP (13) 1 (7.7) 1 (7.7)
Sharma S et al.,
1996 [23]
240 2 0.83 S (2) n/a 1 (50)
Total 5329a 1642 1594 113 3767 110 0.88 HP (59), CR (41),
S + DLI (2), S (7), n/a (1)
36 (32.7) 15 (13.6)
EAS emergency abdominal surgery, HP hartman procedure, S Sigmoidectomy, S + DLI sigmoidectomy + diverting loop ileostomy, CR colonic resection, n/a not available
aAll transplant patients poled together
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ticulitis [2, 4, 18, 23, 32, 37–44] occurring in transplanted
patients and requiring EAS are displayed in Table 3.
Among the most frequent clinical manifestations, there
were fever, abdominal pain, signs of localized or diffuse
peritonitis, anorexia, diarrhea and leukocytosis. Abdom-
inal and pelvic CT scan was performed for all patients,
showing complicated diverticulitis, including free perfora-
tions, phlegmons and abscesses. The surgical approach
was laparotomy in all cases. It consisted in: Hartman’s
procedure in 53.6 % of patients; colon resection with
primary anastomosis in 37.3 %; sigmoidectomy in 6.4 %;
and sigmoidectomy with diverting loop ileostomy in
1.8 %. In 0.9 % of cases the type of surgery performed was
not clearly reported. The immunosuppressive therapy wasmaintained unmodified postoperatively. The morbidity
rate was 32.7 %, with the most frequent complications be-
ing severe respiratory diseases and wound infection. The
overall mortality rate was 13.6 %, in most cases due to
sepsis. No case of acute transplant rejection was reported.
The studies concerning small bowel obstructions
occurring in transplanted patients and requiring EAS
[4, 13, 21, 26, 32, 33, 41] are shown in Table 4. The
most frequent causes of small bowel obstruction were
post-transplantation lymphoproliferative disorders and
mechanical obstruction due to intestinal adhesions.
Abdominal pain, chronic diarrhea and lower gastro-
intestinal bleeding were the most common clinical
signs and symptoms. Abdominal-pelvic CT scan was
performed in most of the patients. In some cases, the
Table 4 Reports of small bowel obstructions requiring EAS after solid organ transplantation
Transplanted organ (n) EAS characteristics and outcomes
Authors, Year Liver Heart Lung Kidney Patients undergoing
EAS (n)






Cruz RJ Jr et al., 2012 [26] 5677 7 0,12 BR (7) n/a 2 (28.6)
Lahon B et al., 2011 [13] 351 3 0.85 BR (3) n/a 0 (0)
Paul S et al., 2009 [4] 208 14 6.73 LA (14) n/a 1 (7.1)
Miller CB et al., 2006 [41] 229 2 0.87 BR (1), LA (1) n/a 1 (50)
Karakayali H et al., 2002 [32] 1038 1 0.10 BR (1) n/a 0 (0)
Andreoni KA et al., 1999 [33] 1417 4 0.28 BR (4) n/a 1 (25)
Bhatia DS et al., 1997 [21] 349 5 1.43 BR (5) 1 (20) 0
Total 5677 349 788 2455 36 0.39 BR (21), LA (15) n/a 5 (13.9)
EAS emergency abdominal surgery, BR bowel resection, LA lysis of adhesions n/a not available
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consisted in exploratory laparotomy, with small bowel
resection in 57.1 % of cases and lysis of adhesions in
42.9 %. The immunosuppressive therapy was maintained
post-operatively or reduced in some patients. The overall
mortality rate was 14.3 %, mostly because of sepsis or as a
direct consequence of surgical complications.
The studies dealing with appendicitis in transplanted
patients requiring EAS [18, 23, 24, 32, 41, 45, 46] are
displayed in Table 5. Abdominal pain was present in
95.5 % of patients, with associated nausea, vomiting, fever,
diarrhea, and leukocytosis. Physical examination demon-
strated right lower quadrant tenderness in 90.1 % of the
patients. Abdominal and pelvic CT scan was performed in
all cases and showed signs of acute appendicitis, including
a non-filling appendix, appendicolith, pericecal stranding,
or free fluid. Furthermore, the 36.3 % of patients under-
went ultrasound examination revealing appendicitis.Table 5 Reports of appendicitis requiring EAS after solid organ tran
Transplanted Organ (n)
Authors, Year Liver Heart Lung Kidney Pancreas Sma
Timrott K et al.,
2014 [24]
342
Miller CB et al.,
2006 [41]
229
Abt PL et al.,
2005 [45]
n/a
Savar A et al.,
2005 [46]
3287 1336 231 3053 6 10
Karakayali H et al.,
2002 [32]
1038
Hoekstra HJ et al.,
2001 [18]
125
Sharma S et al.,
1996 [23]
240
Total 3287a 1918 585 4091 6 10
aexcluding Abt PL et al.’s study for lack of the number of recipients; EAS emergencyThe time from abdominal pain onset to appendectomy
varied from 14 h to 4 days. Pathologic examination
demonstrated appendicitis in 81.8 % of cases. Appendicular
perforation occurred in 22.7 % of patients, more frequently
in those ones operated belatedly. Negative appendectomy
was observed in four specimens (18.2 %). The levels of cal-
cineurin inhibitors were titrated in the post-operative
period and maintained at pre-operative values. Patients re-
ceiving steroids or mycophenolate resumed their pre-
operative dosing immediately after surgery. All patients re-
ceived a minimum of 24 h intravenous antibiotic treatment,
with longer duration for patients with intraperitoneal con-
tamination. The median duration of hospitalization was
6.3 days (range 1–20). No mortality was reported.
Other disorders necessitating EAS in transplanted
patients included complicated incisional hernia,
pancreatic abscess, and splenic infarction. These studies
[23, 47] are shown in Table 6.splantation
EAS characteristics and outcomes
ll Bowel Patients undergoing
EAS (n)




2 0.58 n/a n/a
2 0.87 n/a 0 (0)
7 n/a 2 (28.6) 0 (0)
17 0.21 4 (23.5) 0 (0)
5 0.48 n/a 0 (0)
2 1.6 n/a 0 (0)
1 0.42 n/a 0 (0)
36 0.29a n/a 0 (0)
abdominal surgery, n/a not available
Table 6 Reports of EAS for various indications after solid organ transplantation
Transplanted organ (n) EAS characteristics and outcomes
Authors, Year Liver Heart Indication for EAS Patients undergoing
EAS (n)






Ozgor D et al.,
2014 [47]
173 IH 3 1.73 HRP (3) 1 (33.3) 0 (0)
Sharma S et al.,
1996 [23]
240 PA 2 0.83 DD (2) n/a 0 (0)
Sharma S et al.,
1996 [23]
240 SI 1 0.42 SP (1) n/a 0 (0)
Total 173 240 6 1.45 HRP (3), DD (2),
SP (1)
n/a 0 (0)
EAS emergency abdominal surgery, IH incisional hernia, HRP hernia repair with polypropylene mesh, PA pancreatic abscess, DD debridement/drainage, SI splenic
infarction, SP splenectomy, n/a not available
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Based on the NICE guidelines for the quality assessment
of case series [9], 6 studies received a score of 7/8 [11–13,
27, 28, 39], 31 studies were graded 6/8 [2, 4, 14–16, 18–
23, 25, 26, 29–38, 40–47] and 2 studies 5/8 [17, 24]. Based
on the GRADE system [48], 37 studies [2, 4, 11–16, 18–
23, 25–47] (94.9 %) were judged as being of low quality,
and the remaining 2 studies [17, 24] of very low quality of
evidence. Of note, all studies were retrospective, which, by
definition, are susceptible of major selection bias as well
as misclassification or information bias due to the un-
known accuracy of record keeping. NICE guidelines and
GRADE system quality assessment are displayed in Fig. 2.
Discussion
The present systematic review is the first to analyze the
available literature concerning EAS in transplanted
patients. Emergency surgery after transplantation for
graft-unrelated acute diseases involved 2.5 % of patients,
with the main causes being gallbladder diseases, gastro-
intestinal perforations, complicated diverticulitis, smallFig. 2 Study quality assessment by using the NICE (a) and GRADE (b) systebowel obstructions, and appendicitis. Overall, EAS was
associated with high morbidity (up to 32.7 %) and
mortality (up to 17.5 %) rates, which highlight the
particularly challenging surgical management of trans-
planted patients.
Undoubtedly, one of the most important factors
contributing to the high morbidity and mortality in trans-
planted patients operated for EAS is represented by the
use of several immunosuppressive regimens, most fre-
quently consisting in a triple-drug association: calcineurin
inhibitors, antiproliferative agents, and corticosteriods
[49]. In general, immunosuppressive therapy predisposes
transplanted patients to various gastrointestinal diseases
[50], lymphoproliferative disorders, infective complica-
tions (e.g. Cytomegalovirus, Clostridium difficile), and can
mask the presenting signs and symptoms of many disease
processes. Moreover, immunosuppression is known to
interfere with the patient management for transplant-
unrelated surgical procedures in terms of risk for drug
interactions, adverse effects, wound healing, and postoper-
ative complications [49].ms
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EAS after transplantation, which was mainly reported in
heart-transplanted patients. Despite actual controversies,
the high incidence of biliary tract diseases may be
related to cyclosporine-induced perturbation of bile
composition resulting in an increased prevalence of bil-
iary stones formation [51, 52]. Other putative explana-
tions include vagotomy and associated biliary stasis,
rapid weight loss following transplantation, atheroscler-
osis, and hemolysis [53]. EAS for gallbladder diseases
has been associated with high morbidity (up to 47 %)
[17, 20] and mortality rates (up to 29 %) [17, 19], and
thus a prophylactic cholecystectomy in asymptomatic
patients awaiting transplantation has been proposed as a
strategy to avoid symptomatic gallstone diseases later on
[54, 55]. This may be particularly indicated before heart
and lung transplantation, after which a high incidence of
clinical manifestations and increased mortality has been
reported [19, 56, 57]. However, this approach remains
under debate and it is not routinely performed, also be-
cause an emergency cholecystectomy can be highly prob-
lematic in patients with end-stage diseases [58]. Both
laparoscopy and laparotomy were reported for the surgical
management of emergency related to gallbladder diseases.
Some evidence suggests that patients undergoing open
cholecystectomy develop major post-operative complica-
tions (Dindo-Clavien Classification [59] >3) more fre-
quently than patients operated on by laparoscopy [11].
Other studies showed that laparoscopic cholecystectomy
can be performed safely in lung-, and kidney-transplanted
patients [11, 60], whereas pancreas-transplanted patients
may require specific technical modifications in the laparo-
scopic cholecystectomy procedure, which need to be care-
fully evaluated preoperatively. In the present systematic
review it was not possible to evaluate the rate of post-
operative complications and mortality following EAS for
gallbladder diseases by specific surgical approach. Never-
theless, the overall morbidity and mortality rates appears
to be higher than those found in the literature for non-
transplanted patients (estimated at <1 %) [61–64].
Gastrointestinal perforations were the second most
frequent cause of EAS after solid organ transplantation.
The majority (57.5 %) of the described cases in the lit-
erature occurred in kidney-transplanted patients for
polycystic kidney disease. Although no precise etiology
was found, it seems that transplanted patients for poly-
cystic kidney disease develop more gastrointestinal com-
plications after transplantation than kidney-transplanted
patients for other diseases [33], probably due to several
biologically active substances that influence the alimen-
tary tract and contribute to the increased incidence of
ileus in these patients [65].
In particular, complicated diverticulitis requiring EAS
in transplanted patients showed an incidence rate of0.88 %, which is in accordance with other studies on
transplanted patients (1–4 %) [2, 66, 67] and definitely
higher than in the general population (estimated inci-
dence of 0.025–0.053 %) [42, 68, 69]. The diagnosis and
treatment of diverticulitis after solid organ transplantation
are challenging, since immunosuppressive therapies may
mask presenting signs and symptoms and impair the abil-
ity to contain the infective process [70]. Often, the clinical
manifestation and physical examination do not reflect the
severity of intra-abdominal disease; signs of infection, such
as fever and tachycardia, especially in heart-transplanted
patients, could be absent or highly attenuated. Abdominal
examination and laboratory testing may be irrelevant, and
only the abdominal CT scan appears to be a reliable
diagnostic tool to determine the location and severity of
the disease. Moreover, morbidity and mortality following
emergency colectomy for complicated diverticulitis in
transplanted patients are higher (32.7 and 13.6 %,
respectively) than those observed in immunocompetent
individuals [29, 39].
Another gastrointestinal complication observed in
transplanted patients was small bowel obstruction. The
most frequent etiologies were post-transplant lymphopro-
liferative disorders and mechanical obstruction due to
adhesions. The first disease is usually diagnosed within the
first 2 years after transplantation, and it is strongly associ-
ated with high levels of immunosuppressive drugs [71].
The concomitant involvement of both small and large
bowels may occur in one third of the patients [72]. These
findings stressed the importance of early recognition and
systematic referral for endoscopy of any transplanted
patient with gastrointestinal symptoms, particularly over
the first 2 years after transplantation [26].
Finally, EAS for appendicitis in transplanted patients
was described in 0.29 % of cases, mainly in liver-
transplanted patients (38.9 %). Appendicitis is one of the
most common surgical disease in the general population,
with an estimated lifetime risk of 8.6 % in males and 6.7 %
in females [73], however only few studies are found in
transplanted patients. In all case series, appendectomy
was approached by laparotomy. Only a case report in the
literature describes laparoscopic appendectomy in two
liver and renal transplanted patients with excellent results
similar to those in non-transplanted patients [74]. It must
be noted that appendicitis in transplanted patients is
frequently associated with delayed diagnosis or misdiag-
nosis, which can lead to complicated appendicitis includ-
ing rupture and gangrene. As a general rule, appendicitis
should be aggressively treated to minimize morbidity in
the clinical setting of chronic immunosuppression. Based
on the literature findings, surgical morbidity and
mortality rates associated with this emergency
procedure appear to be much lower than for other
gastrointestinal complications [18].
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regimens were maintained unchanged during the post-
operative period after EAS. Although the heterogeneity
of the literature does not allow pooling data together
and analyzing the direct impact of immunosuppressive
therapies on post-operative complications, the role of
immunosuppression remains crucial since it claims for a
more aggressive treatment of acute abdominal diseases.
On the other hand, this may contribute to have no cases
of graft failure or late rejection following EAS.
Study limitations
The currently available literature on EAS in transplanted
patients for graft-unrelated abdominal diseases is based on
case series only, which represents a low quality of evidence.
However, it may not be feasible to perform randomized
controlled trials or even case–control studies in the setting
of emergency surgery. Moreover, it was not possible in the
present systematic review to perform any quantitative syn-
theses or risk analysis due to the observational nature of
the included studies, the high heterogeneity, and the lack of
control groups. Thus, caution should be paid in the
interpretation of the results since several biases can be
mentioned in the individual studies, such as selection bias,
reporting bias, publication bias, and geographical bias.
However, we tried to control for search biases by searching
the literature on multiple databases, by manual crosscheck
of the reference lists, and by performing the critical
appraisal by two independent reviewers.
Conclusion
Given the growing number of transplantations per year
and the long-term graft survival, EAS for graft-unrelated
acute diseases in transplanted patients is not a rare
event. The risk of misdiagnosis or delayed diagnosis in
chronically immunosuppressed transplanted patients
should be minimized by an attentive evaluation of all
clinical signs and symptoms. Whenever surgery is
indicated, a prompt surgical approach can achieve
satisfactory results. However, even common surgical
emergencies in transplanted patients are associated with
considerable morbidity and mortality. As a general rule,
surgeons treating transplanted patients should proceed
with caution, apply evidence-based protocols, and expect
the unexpected.
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